Trade Summary
On Sep 15, 2026 through Sep 17, 2026, Locke Mark, Insider, sold $5.3M of Genius Sports Ltd (GENI) across 3 transactions. The filing covers Ordinary Shares and reflects net selling of $5.3M. Reported prices ranged from $5.00 to $10.20. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.
Company Information
- Company Name
- Genius Sports Ltd
- Ticker Symbol
- GENI
- CIK
- 0001834489
Insider Information
- Name
- Locke Mark
- Role
- Insider
Filing Details
- Filing Date
- Sep 17, 2026
- Transaction Date
- Sep 15, 2026
- Accession Number
- 0001193125-26-394762
- Form Type
- 4
- Net Trading Amount
- -$5.3M
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Ordinary Shares | 477,449 | $6.58 | Sale | $3.1M |
| Sep 16, 2026 | Ordinary Shares | 272,551 | $6.56 | Sale | $1.8M |
| Sep 17, 2026 | Ordinary Shares | 50,000 | $6.54 | Sale | $327.1K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | GENI derivative | 1 | $10.20 | Sale | $10 |
| Sep 15, 2026 | GENI derivative | 1 | $5.00 | Purchase | $5 |
Want live alerts when Locke Mark trades again?
Download Insider Trades to track GENI, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.
Footnotes
- (F1)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.4663 to $6.7219. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F2)The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.4998 to $6.6795. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- (F3)On September 15, 2026 the Reporting Person entered into a 'zero cost collar' arrangement (the "Transactions") pursuant to which they wrote European call options and purchased American put options over an aggregate 4,400,000 Ordinary Shares. Only one of the options can be in the money on the expiration date, at which time the in-the-money options will be exercised, and the other options will expire. If neither the put options nor the call options are in the money on the expiration date, both will expire. The Transactions will be settled in cash unless the Reporting Person elects physical settlement. The Transactions are 'zero cost collars' in which no premium was exchanged for either the call options or the put options.